About
Technology
Issues
FAQ
Links
Official Page
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.